Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Focused on muscle and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Jan 11, 2021
Document Date
Jan 11, 2021
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.